Clinical Services > Pharmacy

Pharmacy body spotlights member priorities for 2025–26 Budget

06 February, 2025

Advanced Pharmacy Australia (AdPha) has scope of practice, workforce sustainability and medicines shortages as member priorities in its pre-Budget spotlight.


Lung cancer medication gets PBS listing

04 February, 2025

The Australian Government is listing Retevmo (selpercatinib) on the Pharmaceutical Benefits Scheme, with around 130 patients expected to benefit each year.


Paracetamol pack size changes come into effect on 1 February 2025

24 January, 2025

The Therapeutic Goods Administration's decision to reduce pack sizes of paracetamol to help prevent misuse will come into effect on 1 February 2025.


Building awareness around deprescribing and sustainability

14 January, 2025 by Kristin Michaels, Chief Executive of Advanced Pharmacy Australia (AdPha)

MedsAware Deprescribing Action Week from 10–16 March is designed to raise awareness around polypharmacy and deprescribing.


WA, Qld expand pharmacists' scope

14 August, 2024

Western Australia has expanded the role of community pharmacists following the success of uncomplicated urinary tract infection (UTI) treatment program that is said to have helped 7000 patients across the state.


Opinion: Advanced pharmacy is not revolutionary, it’s evolutionary

05 August, 2024 by Tom Simpson, President, SHPA

As the most common healthcare intervention, medicines are crucial to all aspects of Australians' health.


Deprescribing guidelines falling short: study

17 June, 2024

More than two-thirds of clinical practice guidelines do not contain any recommendations on deprescribing, reveals a new study led by Monash University.


Telstra Health to fully acquire pharmacy tech company Fred IT

31 May, 2024

The investment is the evolution of a 10-year joint venture partnership between both the organisations.


How a Pharmaceutical Giant Ensures the Safety and Authenticity of Medicines Through Serialisation

21 March, 2024

In an era where pharmaceutical traceability is paramount, Aspen Australia, a subsidiary of Aspen Pharmacare Holdings Limited, has emerged as a trailblazer in implementing robust global standards to combat the threat of falsified medicines.


Study lists 16 potentally risky medicines in Aust health care

06 February, 2024

Researchers from the RMIT have developed a list of potentially dangerous medications used in Australia and have also suggested safer alternatives.


RACGP calls for long-term solution to opioid dependence

22 November, 2023

While welcoming a decision to extend the period GPs can adminster opioid dependence treatment drugs, a longer-term solution is needed, RACGP says.  


Pharmacist-led prescribing: nationalised approach, a step closer

28 September, 2023 by Tom Simpson*

Earlier in the year I shared my views on the future of pharmacy noting pharmacist-led prescribing as one of the key areas of pharmacist specialisation that would help address the increasingly complex nature of health care.


New pharmacy recognition program launched

26 September, 2023

The Society of Hospital Pharmacists of Australia (SHPA) has launched a recognition program hoping to transform pharmacy practice in Australia and New Zealand.


Report examines overuse and misuse of antibiotics given to children

04 September, 2023

A study by Charles Darwin University found that parental decision on antibiotic use comes based on factors of personal advice, fear and access to healthcare institutions.


PSA launches updated Professional Practice Standards

07 August, 2023

The PSA has released revised Professional Practice Standards for clinical activities undertaken by pharmacists in differing specialty areas.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd